Patients with a rare disease called mucous membrane pemphigoid are at risk of developing squamous cell carcinoma and basal cell carcinoma, finds a new study.

The following is a summary of "Artificial Intelligence in Early Screening for Esophageal Squamous Cell carcinoma," published in the March 2025 issue of Best Practice & Research Clinical ...

On March 5, 2025, the FDA cleared an investigational new drug application for CTD402, a CD7-targeted universal CAR T-cell therapy, for the treatment of pediatric and adult patients with ...

Global development program for JNJ-1900 (NBTXR3) proceeding as planned, with opportunity to address one of the largest untapped markets in ...

Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

A patient-derived organoid library of esophageal squamous cell carcinoma (ESCC) identifies chemotherapy (chemo)-resistant ESCC organoids (ESCCOs) and reveals the molecular basis, biomarkers ...

Neoadjuvant chemoimmunotherapy is associated with significantly improved survival outcomes compared with standard ...

From April 25 to 30, 2025, the American Association for Cancer Research (AACR) Annual Meeting will take place in Chicago. CStone will showcase its latest preclinical studies on five internally ...

Esophageal squamous cell carcinoma (ESCC) accounts for about 90% of esophageal cancer cases and is the sixth most common cause of cancer death worldwide. Targeting cancer stem cells offers a ...

Squamous cell carcinoma. Most people think of skin cancer when they hear the words "squamous cell carcinoma." And it is true that this type of carcinoma often shows up on the skin. But squamous ...

Century Therapeutics has joined the onslaught of cell therapy biotechs taking hits, discontinuing a phase 1 cancer study to turn its focus toward autoimmune diseases. The move isn’t shocking ...